By Akane Asami

Iraola Emerges as Top Target After Bournemouth Exit

Premier League managerial dynamics have taken a fresh turn following the confirmed departure of Andoni Iraola from AFC Bournemouth, with top-flight clubs already positioning themselves to secure his services amid an increasingly competitive coaching market. Iraola’s exit has immediately triggered interest from several Premier League sides, most notably Manchester United, where uncertainty surrounding the current…

Read More

Singapore, world’s top ship-fuelling hub, grapples with tightening supply

Singapore — The world’s largest ship-refuelling hub is facing mounting pressure as global fuel supply disruptions ripple through Asia, tightening availability and pushing prices sharply higher. Singapore, which handles the largest share of global bunkering demand, has seen marine fuel costs surge amid supply shocks linked to geopolitical tensions in the Middle East and export…

Read More

Rohm and Toshiba Consider Power Semiconductor Alliance

Two of Japan’s leading electronics companies, Rohm Co., Ltd. and Toshiba Corporation, are reportedly exploring the possibility of integrating their power semiconductor operations in a move that could strengthen Japan’s position in the rapidly expanding global chip industry. According to sources familiar with the discussions, the companies are currently engaged in preliminary talks aimed at…

Read More

Alysa Liu’s Father Speaks After Olympic Gold, Reveals China Outreach and Message to Donald Trump

Following figure skater Alysa Liu’s rise to Olympic glory, her father has offered a candid reflection on success, politics, and what he says “money can’t buy.” The Tiananmen-era activist, who fled China decades ago, revealed that Chinese officials had previously expressed interest in courting his daughter as her skating career accelerated on the global stage….

Read More

Sumitomo Pharma Seeks Approval for Groundbreaking Stem Cell Therapy for Parkinson’s Disease.

Japanese pharmaceutical giant Sumitomo Pharma has filed for regulatory approval of its innovative stem cell-based therapy for Parkinson’s disease, marking a major milestone in the global race to develop a regenerative treatment for the debilitating neurological disorder. The submission was made to Japan’s Pharmaceuticals and Medical Devices Agency (PMDA) and represents the world’s first formal…

Read More